Triangle-based Basking Biosciences raises $27.5 million
A Research Triangle Park-based biotechnology company working on a drug to treat strokes has raised $27.5 million from investors, according to a Securities and Exchange Commission f…
A Research Triangle Park-based biotechnology company working on a drug to treat strokes has raised $27.5 million from investors, according to a Securities and Exchange Commission f…